146 related articles for article (PubMed ID: 31960918)
1. Kinetics of Hepatitis B Core-Related Antigen and Anti-Hepatitis B Core Antibody and Their Association With Serological Response in Human Immunodeficiency Virus-Hepatitis B Coinfection.
Dezanet LNC; Maylin S; Gabassi A; Rougier H; Miailhes P; Lascoux-Combe C; Chas J; Girard PM; Delaugerre C; Lacombe K; Boyd A
J Infect Dis; 2020 May; 221(11):1826-1837. PubMed ID: 31960918
[TBL] [Abstract][Full Text] [Related]
2. Association of Hepatitis B Core-Related Antigen and Antihepatitis B Core Antibody With Liver Fibrosis Evolution in Human Immunodeficiency Virus-Hepatitis B Virus Coinfected Patients During Treatment With Tenofovir.
Cruchet R; Dezanet LNC; Maylin S; Gabassi A; Rougier H; Miailhes P; Lascoux-Combe C; Chas J; Girard PM; Delaugerre C; Lacombe K; Boyd A
Open Forum Infect Dis; 2020 Jul; 7(7):ofaa215. PubMed ID: 33123612
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.
Boyd A; Maylin S; Moh R; Mahjoub N; Gabillard D; Eholié SP; Danel C; Anglaret X; Zoulim F; Girard PM; Delaugerre C; Lacombefor K;
J Gastroenterol Hepatol; 2016 Mar; 31(3):634-44. PubMed ID: 26313291
[TBL] [Abstract][Full Text] [Related]
4. Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon.
Hou FQ; Song LW; Yuan Q; Fang LL; Ge SX; Zhang J; Sheng JF; Xie DY; Shang J; Wu SH; Sun YT; Wei SF; Wang MR; Wan MB; Jia JD; Luo GH; Tang H; Li SC; Niu JQ; Zhou WD; Sun L; Xia NS; Wang GQ
Theranostics; 2015; 5(3):218-26. PubMed ID: 25553110
[TBL] [Abstract][Full Text] [Related]
5. Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients.
Hu HH; Liu J; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; Quan Y; Xia NS; Chen CJ; Chen PJ; Yang HI
Clin Gastroenterol Hepatol; 2019 Jan; 17(1):172-181.e1. PubMed ID: 29753083
[TBL] [Abstract][Full Text] [Related]
6. Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients.
Li MR; Lu JH; Ye LH; Sun XL; Zheng YH; Liu ZQ; Zhang HC; Liu YY; Lv Y; Huang Y; Dai EH
Medicine (Baltimore); 2016 Aug; 95(34):e4422. PubMed ID: 27559949
[TBL] [Abstract][Full Text] [Related]
7. Correlations between serum hepatitis B surface antigen and hepatitis B core antibody titers and liver fibrosis in treatment-naïve CHB patients.
Li MR; Zheng HW; Ma SM; Liu YY; Qie LX; Li JQ; Wang DH; Sun XL; Ren GF; Zheng YH; Wang YL; Dai EH
J Chin Med Assoc; 2018 Dec; 81(12):1052-1059. PubMed ID: 30143430
[TBL] [Abstract][Full Text] [Related]
8. Serum hepatitis B core antibody titer use in screening for significant fibrosis in treatment-naïve patients with chronic hepatitis B.
Li MR; Zheng HW; Lu JH; Ma SM; Ye LH; Liu ZQ; Zhang HC; Liu YY; Lv Y; Huang Y; Dai EH; Sun DX
Oncotarget; 2017 Feb; 8(7):11063-11070. PubMed ID: 28052021
[TBL] [Abstract][Full Text] [Related]
9. Anti-HBc IgG Levels: A Predictor of HBsAg Seroclearance in Chronic Hepatitis B Patients with Nucleos(t)ide Analogue-Induced HBeAg Seroclearance.
Kim S; Yoo S; Lee JI; Kim S; Chang HY; Kim D; Jeong SH; Lee KS; Lee HW
Dig Dis Sci; 2022 Jan; 67(1):321-328. PubMed ID: 33517556
[TBL] [Abstract][Full Text] [Related]
10. Baseline serum hepatitis B core antibody level predicts HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B after antiviral treatment.
Zhao XA; Wang J; Liu J; Chen G; Yan X; Jia B; Yang Y; Liu Y; Gu D; Zhang Z; Xiang X; Huang R; Wu C
Antiviral Res; 2021 Sep; 193():105146. PubMed ID: 34314774
[TBL] [Abstract][Full Text] [Related]
11. Intensification with pegylated interferon during treatment with tenofovir in HIV-hepatitis B virus co-infected patients.
Boyd A; Piroth L; Maylin S; Maynard-Muet M; Lebossé F; Bouix C; Lascoux-Combe C; Mahjoub N; Girard PM; Delaugerre C; Carrat F; Lacombe K; Miailhes P
J Viral Hepat; 2016 Dec; 23(12):1017-1026. PubMed ID: 27486094
[TBL] [Abstract][Full Text] [Related]
12. Comparison of hepatitis B virus core-related antigen and hepatitis B surface antigen for predicting HBeAg seroconversion in chronic hepatitis B patients with pegylated interferon therapy.
Wang ML; Liao J; Wei B; Zhang DM; He M; Tao MC; Chen EQ; Tang H
Infect Dis (Lond); 2018 Jul; 50(7):522-530. PubMed ID: 29463147
[TBL] [Abstract][Full Text] [Related]
13. Use of hepatitis B surface and "e" antigen quantification during extensive treatment with tenofovir in patients co-infected with HIV-HBV.
Boyd A; Maylin S; Gozlan J; Delaugerre C; Simon F; Girard PM; Lacombe K
Liver Int; 2015 Mar; 35(3):795-804. PubMed ID: 24606220
[TBL] [Abstract][Full Text] [Related]
14. Correlation of serum hepatitis B core-related antigen with hepatitis B virus total intrahepatic DNA and covalently closed circular-DNA viral load in HIV-hepatitis B coinfection.
Dezanet LNC; Maylin S; Gabassi A; Rougier H; Miailhes P; Lascoux-Combe C; Chas J; Girard PM; Delaugerre C; Zoulim F; Lacombe K; Boyd A
AIDS; 2020 Nov; 34(13):1943-1949. PubMed ID: 32773480
[TBL] [Abstract][Full Text] [Related]
15. Rates and determinants of hepatitis B 'e' antigen and hepatitis B surface antigen seroclearance during long-term follow-up of patients coinfected with HIV and hepatitis B virus.
Boyd A; Gozlan J; Miailhes P; Lascoux-Combe C; Cam MS; Rougier H; Zoulim F; Girard PM; Lacombe K
AIDS; 2015 Sep; 29(15):1963-73. PubMed ID: 26153669
[TBL] [Abstract][Full Text] [Related]
16. Quantitative anti-HBc combined with quantitative HBsAg can predict HBsAg clearance in sequential combination therapy with PEG-IFN-α in NA-suppressed chronic hepatitis B patients.
Wang WX; Jia R; Gao YY; Liu JY; Luan JQ; Qiao F; Liu LM; Zhang XN; Wang FS; Fu J
Front Immunol; 2022; 13():894410. PubMed ID: 35958609
[TBL] [Abstract][Full Text] [Related]
17. Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection.
Song LW; Liu PG; Liu CJ; Zhang TY; Cheng XD; Wu HL; Yang HC; Hao XK; Yuan Q; Zhang J; Kao JH; Chen DS; Chen PJ; Xia NS
Clin Microbiol Infect; 2015 Feb; 21(2):197-203. PubMed ID: 25658546
[TBL] [Abstract][Full Text] [Related]
18. Baseline HBsAg and HBcrAg titres allow peginterferon-based 'precision medicine' in HBeAg-negative chronic hepatitis B patients.
Martinot-Peignoux M; Lapalus M; Maylin S; Boyer N; Castelnau C; Giuily N; Pouteau M; Moucari R; Asselah T; Marcellin P
J Viral Hepat; 2016 Nov; 23(11):905-911. PubMed ID: 27375231
[TBL] [Abstract][Full Text] [Related]
19. Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Children With a Normal Alanine Aminotransferase Level.
Chen HS; Wu JF; Su TH; Chen HL; Hsu HY; Xia NS; Chen PJ; Chang MH
Hepatology; 2019 Dec; 70(6):1903-1912. PubMed ID: 31121067
[TBL] [Abstract][Full Text] [Related]
20. Serum hepatitis B core-related antigen as a surrogate marker of hepatitis B e antigen seroconversion in chronic hepatitis B.
Chi XM; Wang XM; Wang ZF; Wu RH; Gao XZ; Xu HQ; Ding YH; Niu JQ
World J Gastroenterol; 2021 Oct; 27(40):6927-6938. PubMed ID: 34790015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
